Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Pulse Therapeutics (St. Louis, MO) a development-stage medical device company focused on vascular drug delivery device for blood clots in stroke patients , closed a $3.1M Series B financing. Participants include BioGenerator.

Pulse Therapeutics (St. Louis, MO) a development-stage medical device company focused on vascular drug delivery device for blood clots in stroke patients, closed a $3.1M Series B financing. Participants include BioGenerator.

MindFrame (Lake Forrest, CA) developer of devices for ischemic stroke treatment, closed a $6M Series A financing. Participants include SV Life Sciences and Intersect Partners.

Aldagen (Durham, NC) development-stage biopharmaceutical company focused on regenerative cell therapies, closed a $18.M Series D financing. Participants include Intersouth Partners, Tullis-Dickerson, Harbert Venture Partners, and The Aurora Funds.

CoAxia (Maple Grive, MN) development-stage medical device company focused on a catheter-based therapy for cerebral ischemia, closed a $11.5M Series C financing. Participants include Canaan Partners, Prism Venture Partners, Baird Venture Partners, Affinity Capital Management, Johnson and Johnson Development Corporation and SVB Capital Partners.

  

to top of page...